Publications by authors named "Cheng-Bo Han"

Claim this Profile
C
Comparative efficacy of first-line therapies for PD-L1-negative advanced NSCLC: A network meta-analysis with reconstructed survival curves.
Jie-Tao Ma, Mei-Qi Yang, Shu-Ling Zhang, Le-Tian Huang, Li Sun, Cheng-Bo Han

Crit Rev Oncol Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells.
Mei-Qi Yang, Shu-Ling Zhang, Li Sun, Le-Tian Huang, Jing Yu, Jie-Hui Zhang, Cheng-Bo Han

Mol Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Optimal First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer Based on Liver Metastasis Status: A Network Meta-Analysis and Systematic Review.
Shu-Ling Zhang, Jing Yu, Yuan Tian, Jie-Hui Zhang, Li Sun, Cheng-Bo Han

Cancer Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of the lay health advisor program on oral function and quality of life in aboriginal older adults: A randomized controlled trial.
Bo-Han Cheng, Pei-Shan Ho, Chih-Cheng Hsu, Fu-Li Chen, Ming-An Chen

J Oral Rehabil· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is neoadjuvant immunotherapy necessary in patients with programmed death ligand 1 expression-negative resectable non-small cell lung cancer? A systematic review and meta-analysis.
Shu-Ling Zhang, Yuan Tian, Jing Yu, Jie-Hui Zhang, Li Sun, Cheng-Bo Han

Lung Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Genome-wide identification of bZIP family genes and screening of candidate AarbZIPs involved in terpenoid biosynthesis in Artemisia argyi].
Bo-Han Cheng, Meng-Yue Wang, Lan Wu, Ran-Ran Gao, Qing-Gang Yin

Zhongguo Zhong Yao Za Zhi· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trials.
Shu-Ling Zhang, Xiao-Fang Yi, Le-Tian Huang, Li Sun, Jie-Tao Ma, Cheng-Bo Han

BMC Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual antitumor immunomodulatory effects of PARP inhibitor on the tumor microenvironment: A counterbalance between anti-tumor and pro-tumor.
Xiao-Fang Yi, Ruo-Lin Gao, Li Sun, Zhi-Xuan Wu, Shu-Ling Zhang, Cheng-Bo Han

Biomed Pharmacother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis from 23 prospective studies.
Ruo-Lin Gao, Jun Song, Li Sun, Zhi-Xuan Wu, Xiao-Fang Yi, Shu-Ling Zhang, Cheng-Bo Han

Front Pharmacol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysis.
Xiao-Fang Yi, Jun Song, Ruo-Lin Gao, Li Sun, Zhi-Xuan Wu, Shu-Ling Zhang, Cheng-Bo Han

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of EGFR exon 19 deletion subtypes on clinical outcomes in EGFR-TKI-Treated advanced non-small-cell lung cancer.
Le-Tian Huang, Shu-Ling Zhang, Cheng-Bo Han, Jie-Tao Ma

Lung Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Jie-Tao Ma, Yi-Jia Guo, Jun Song, Li Sun, Shu-Ling Zhang, Cheng-Bo Han

Biomed Res Int· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of randomized control trials.
Le-Tian Huang, Rui Cao, Yan-Ru Wang, Li Sun, Xiang-Yan Zhang, Shu-Ling Zhang, Cheng-Bo Han

BMC Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term outcomes and safety of radiotherapy for immediate breast reconstruction with autologous flap transfer following breast-conserving surgery.
Shu-Ling Zhang, Jun Song, Yan-Ru Wang, Yi-Jia Guo, Jian-Zhu Zhao, Cheng-Bo Han

BMC Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials.
Li Sun, Yi-Jia Guo, Jun Song, Yan-Ru Wang, Shu-Ling Zhang, Cheng-Bo Han

Front Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysis.
Shu-Ling Zhang, Cheng-Bo Han, Li Sun, Le-Tian Huang, Jie-Tao Ma

Radiat Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Breast Cancer Coexisting With HER-2 Amplification and EGFR Exon 19 Deletion Benefits From EGFR-TKI Therapy: A Case Report.
Wei Jing, Jie-Tao Ma, Cheng-Bo Han

Front Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pulmonary interstitial lesions on efficacy and prognosis of EGFR-TKI-treated advanced non-small cell lung cancers.
Xiang-Yan Zhang, Rui Cao, Yi-Jia Guo, Yan-Hua Zhen, Jia-He Zheng, Shu-Ling Zhang, Cheng-Bo Han

J Thorac Dis· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case Report.
Le-Tian Huang, Jie-Tao Ma, Shu-Ling Zhang, Xiao-Han Li, Li Sun, Cheng-Bo Han

Front Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational application of the first-line chemotherapy and immune checkpoint inhibitors in advanced nonsmall cell lung cancer: A meta-analysis.
Rui Cao, Jie-Tao Ma, Shu-Ling Zhang, Li Sun, Yang Liu, Xiang-Yan Zhang, Cheng-Bo Han

Cancer Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of tumor heterogeneity on sensitivity of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIs.
Li Sun, Yao-Yong Li, Jie-Tao Ma, Shu-Ling Zhang, Le-Tian Huang, Cheng-Bo Han

Transl Cancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of apatinib in combination with osimertinib on EGFR T790M-positive lung adenocarcinoma.
Yang Liu, Zhi-Cheng Xiong, Xin Sun, Li Sun, Shu-Ling Zhang, Cheng-Bo Han

Transl Cancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Dynamin-related Protein 1 Regulated Mitochondrial Dynamic Changes on Invasion and Metastasis of Lung Cancer Cells.
Jie-Tao Ma, Xiang-Yan Zhang, Rui Cao, Li Sun, Wei Jing, Shu-Ling Zhang, Cheng-Bo Han

J Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chest Wall Toxicity After Stereotactic Body Radiation Therapy: A Pooled Analysis of 57 Studies.
Jie-Tao Ma, Yang Liu, Li Sun, Michael T Milano, Shu-Ling Zhang, Cheng-Bo Han

Int J Radiat Oncol Biol Phys· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of apatinib in patients with advanced nonsmall cell lung cancer that failed prior chemotherapy or EGFR-TKIs: A pooled analysis.
Jie-Tao Ma, Jing Sun, Li Sun, Shu-Ling Zhang, Le-Tian Huang, Cheng-Bo Han

Medicine (Baltimore)· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis